|

5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug. Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • michal roll1

Indications

  • Surgical Resection1
  • Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After1
  • The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an1
  • Cancer1

Other1 trial

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.